The London based health tech startup has raised pre-seed capital from international backers to scale its rapid pharmacy delivery service.
"This funding round has allowed us to introduce a product to market that will serve the digital patient at a crucial time. Against a backdrop of increased uncertainty within the NHS, including strikes and supply chain issues, Healistic aims to alleviate these pressures by connecting patients to the appropriate healthcare solutions through a trusted, centralised system. We believe that immediate healthcare should be accessible to everyone. Healistic is building a category leader in the ‘Open Healthcare’ revolution, a parallel to the ‘Open Banking’ revolution, which began in the last decade."
Beringea led the growth round for the patient review platform, with continued support from Keen Venture Partners, Amadeus Capital Partners, and Guinness Ventures.
"Our health is the most precious thing we have. With Doctify, we are working on building the world’s most important healthcare platform to help millions of patients. We are excited to welcome our new investors, Beringea, whom we first met years ago, and we are delighted with the support of our existing investors."
The funding round was backed by a group of existing investors alongside a grant from the European Innovation Council.
"This is a very significant funding milestone in our mission to detect cancer early and improve survival and quality of life for patients. Having demonstrated our multi-cancer capability, we can now focus on building the pipeline of organ-specific tests, beginning with a multi-center study to gain regulatory approval for the brain cancer test. We will also expand our data on colorectal cancer, one of the leading causes of death worldwide, and continue our work on collaborative projects."
The Leeds-based health app secured £1.5m through NorthInvest to scale patient access across the North of England.
"We’re incredibly pleased to announce this milestone in our company’s journey. With the help of NorthInvest’s angel investment network, we will be able to bring our services to over 50,000 more waiting patients and expand our primary care services in the North of the UK."
The medtech startup will use the fresh capital to bring its pharmacist digitisation software to market.
"Using just an NHS number, we can create personalised, contextualised insights that will help people stay well. We’re so grateful to receive this additional Innovate UK backing so we can scale this application of our software and move a step closer towards creating a single source of truth for medicines data in the UK."
